[PDF][PDF] Minimal residual disease monitoring in chronic myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation using interphase …
HQ Zhu, XL Liu, LL Song, QF Liu, FY Meng… - Chin J …, 2010 - scholar.archive.org
… During the treatment for CML, it is necessary to conduct a dynamic monitoring on tumor
burden, so as to modify treatment scheme and achieve a complete cytogenetic remission (CCR, …
burden, so as to modify treatment scheme and achieve a complete cytogenetic remission (CCR, …
[HTML][HTML] 苯所致慢性髓性白血病5 例临床分析
詹昱, 杨志前, 曲佳, 冯可欣, 杨郁青, 谭明珠… - 职业卫生与应急 …, 2021 - oher.com.cn
… 获完全细胞遗传学反应(complete cytogenetic response,CCyR),12个月时… chronic myelogenous
leukemia(CML)caused by benzene, so as to strengthen prevention and standard treatment…
leukemia(CML)caused by benzene, so as to strengthen prevention and standard treatment…
Arsenic-containing qinghuang powder (青黄散) is an alternative treatment for elderly acute myeloid leukemia patients refusing low-intensity chemotherapy
T Fan, R Quan, W Liu, H Xiao, X Tang, C Liu… - Chinese journal of …, 2020 - Springer
… At the initial diagnosis, 27 patients were tested for cytogenetics. The … treat patients with
myeloid leukemia for approximately 50 year-old , as well as those with chronic myeloid leukemia (…
myeloid leukemia for approximately 50 year-old , as well as those with chronic myeloid leukemia (…
[HTML][HTML] … Comments Off on The US FDA has issued full approval for Israeli drugmaker Teva's Synribo (omacetaxine mepesuccinate) 高三尖杉酯碱for chronic myeloid …
OFT BLOG - allfordrugs.com
… the treatment of adult patients with chronic myeloid leukemia (… resistant T315I mutation
achieved cytogenetic response in 28… The present new method uses a special biochemical agent …
achieved cytogenetic response in 28… The present new method uses a special biochemical agent …
[HTML][HTML] RDW 对初诊慢性粒细胞白血病慢性期患者TKI 治疗反应的早期预测价值
胡金花, 徐子瑶, 孙倩, 刘文洁, 洪鸣… - 南京医科大学学报(自然 …, 2022 - jnmu.njmu.edu.cn
… Early molecular and cytogenetic response is predictive for long⁃term … at diagnose is a simple
negative prognostic factor in chronic phase⁃chronic myeloid leukemia patients treated with …
negative prognostic factor in chronic phase⁃chronic myeloid leukemia patients treated with …
荧光原位杂交技术在异基因造血干细胞移植监测中的作用**★
莫耀禧, 周瑞莲, 莫伟英, 蓝梅, 林金盈 - 中国组织工程研究, 2012 - cjter.com
… Molecular cytogenetic monitoring of chimerism and minimal residual disease in patient with
chronic myeloid leukemia after allogenic and syngenic bone marrow transplantation.Ter Arkh…
chronic myeloid leukemia after allogenic and syngenic bone marrow transplantation.Ter Arkh…
[PDF][PDF] 早幼粒细胞白血病分子遗传学诊疗技术在临床中的应用
宋鹏, 张鑫, 赵海岳, 佟菲, 周晋 - 现代生物医学进展, 2012 - biomed.cnjournals.com
… Methods: We tested chromosomal abnormalities in bone marrow samples from 83 patients
with … Cytogenetic dynamic detection in chronic myeloid leukemia in application [J]. Journal of …
with … Cytogenetic dynamic detection in chronic myeloid leukemia in application [J]. Journal of …
Relation of blood arsenic concentration with effect and safety of arsenic-containing Qinghuang Powder (青黄散) in patients with myelodysplastic syndrome
Z Deng, S Zhu, M Wang, S Fang, P Zhao, Q Zhu… - Chinese journal of …, 2019 - Springer
… myeloid leukemia cells progressed from MDS,(13-16) which might explain one of the
mechanisms of QHP in the treatment … with other karyotypes, based on cytogenetics. As well as, …
mechanisms of QHP in the treatment … with other karyotypes, based on cytogenetics. As well as, …
造血干细胞移植治疗地中海贫血
吴学东, 井远方, 温建芸, 刘华颖, 王彦华, 李春富 - 中国组织工程研究, 2012 - cjter.com
… Evolving concepts in the management of chronic myeloid leukemia: recommendations from
… Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl …
… Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl …
[PDF][PDF] 分子生物学在血液病诊断和治疗中的应用及研究进展
史美玉, 唐诗哲, 徐挺亮, 周凯燕… - Progress in Modern …, 2020 - biomed.cnjournals.com
… The application of molecular biological methods in the diagnosis and … oncoprint of
recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia[J]. …
recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia[J]. …